Abstract
The study aimed to investigate the correlations of CACNA1C genetic polymorphisms and protein expression with the pathogenesis of schizophrenia in a Chinese population. This research included 139 patients diagnosed with schizophrenia (case group) and 141 healthy volunteers (control group). Case and control samples were genotyped using denaturing high-performance liquid chromatography (DHPLC). Haplotypes of rs10848683, rs2238032, and rs2299661 were analyzed using the Shesis software. A mouse model of schizophrenia was established and assigned to test and blank groups. Western blotting was used to detect CACNA1C protein expression. The genotype and allele distribution of rs2238032 and rs2299661 differed between the case and control groups. TT genotype of rs2238032 and G allele of rs2299661 could potentially reduce the risk of schizophrenia. The distribution of rs2238032 genotype has a close connection with cognitive disturbance and the results of the general psychopathology classification exam. The distribution of rs2299661 genotypes was closely related to sensory and perceptual disorders, negative symptom subscales, and the results of the general psychopathology classification exam. CTC haplotype increased and CTG decreased the risk of schizophrenia in healthy people. In the brain tissues of mice with schizophrenia, the CACNA1C protein expression was higher in the test group than in the blank group. Our study demonstrated that CACNA1C gene polymorphisms and CACNA1C protein expression were associated with schizophrenia and its clinical phenotypes.
Similar content being viewed by others
References
Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60(12):1187–1192
Tsuang MT, Stone WS, Faraone SV (2001) Genes, environment and schizophrenia. Br J Psychiatry Suppl 40:s18–s24
Wexler EM, Geschwind DH (2011) DISC1: a schizophrenia gene with multiple personalities. Neuron 72(4):501–503
Sun F, Stock EM, Copeland LA, Zeber JE, Ahmedani BK, Morissette SB (2014) Polypharmacy with antipsychotic drugs in patients with schizophrenia: trends in multiple health care systems. Am J Health Syst Pharm 71(9):728–738
Konradi C, Heckers S (2001) Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biol Psychiatry 50(10):729–742
Soldatov NM (2013) Cav1.2, cell proliferation, and new target in atherosclerosis. ISRN Biochem 2013(463527
Hofmann F, Flockerzi V, Kahl S, Wegener JW (2014) L-type CaV1.2 calcium channels: from in vitro findings to in vivo function. Physiol Rev 94(1):303–326
Bhat S, Dao DT, Terrillion CE, Arad M, Smith RJ, Soldatov NM, Gould TD (2012) CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. Prog Neurobiol 99(1):1–14
Leitch B, Szostek A, Lin R, Shevtsova O (2009) Subcellular distribution of L-type calcium channel subtypes in rat hippocampal neurons. Neuroscience 164(2):641–657
Barad M (2003) Later developments: molecular keys to age-related memory impairment. Alzheimer Dis Assoc Disord 17(3):168–176
Dao DT, Mahon PB, Cai X, Kovacsics CE, Blackwell RA, Arad M, Shi J, Zandi PP, O'Donnell P, Bipolar Genome Study C, Knowles JA, Weissman MM, Coryell W, Scheftner WA, Lawson WB, Levinson DF, Thompson SM, Potash JB, Gould TD (2010) Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans. Biol Psychiatry 68(9):801–810
Szumlinski KK, Lominac KD, Kleschen MJ, Oleson EB, Dehoff MH, Schwarz MK, Seeburg PH, Worley PF, Kalivas PW (2005) Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain Behav 4:273–288
Kim HJ, Eom CY, Kwon J, Joo J, Lee S, Nah SS, Kim IC, Jang IS, Chung YH, Kim SI, Chung JH, Choi JS (2012) Roles of interferon-gamma and its target genes in schizophrenia: proteomics-based reverse genetics from mouse to human. Proteomics 12:1815–1829
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22–33 quiz 34-57
Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276
Scola G, Laliberte VL, Kim HK, Pinguelo A, Salvador M, Young LT, Andreazza AC (2014) Vitis labrusca extract effects on cellular dynamics and redox modulations in a SH-SY5Y neuronal cell model: a similar role to lithium. Neurochem Int 79:12–19
Hennessey JA, Boczek NJ, Jiang YH, Miller JD, Patrick W, Pfeiffer R, Sutphin BS, Tester DJ, Barajas-Martinez H, Ackerman MJ, Antzelevitch C, Kanter R, Pitt GS (2014) A CACNA1C variant associated with reduced voltage-dependent inactivation, increased CaV1.2 channel window current, and arrhythmogenesis. PLoS One 9(9):e106982
Arts B, Simons CJ, Os J (2013) Evidence for the impact of the CACNA1C risk allele rs1006737 on 2-year cognitive functioning in bipolar disorder. Psychiatr Genet 23(1):41–42
Frazier TW, Youngstrom EA, Frankel BA, Zunta-Soares GB, Sanches M, Escamilla M, Nielsen DA, Soares JC (2014) Candidate gene associations with mood disorder, cognitive vulnerability, and fronto-limbic volumes. Brain Behav 4(3):418–430
Backes H, Dietsche B, Nagels A, Konrad C, Witt SH, Rietschel M, Kircher T, Krug A (2014) Genetic variation in CACNA1C affects neural processing in major depression. J Psychiatr res 53:38–46
He K, An Z, Wang Q, Li T, Li Z, Chen J, Li W, Wang T, Ji J, Feng G, Lin H, Yi Q, Shi Y (2014) CACNA1C, schizophrenia and major depressive disorder in the Han Chinese population. Br J Psychiatry 204(1):36–39
Gomez-Ospina N, Panagiotakos G, Portmann T, Pasca SP, Rabah D, Budzillo A, Kinet JP, Dolmetsch RE (2013) A promoter in the coding region of the calcium channel gene CACNA1C generates the transcription factor CCAT. PLoS One 8(4):e60526
Striessnig J, Koschak A, Sinnegger-Brauns MJ, Hetzenauer A, Nguyen NK, Busquet P, Pelster G, Singewald N (2006) Role of voltage-gated L-type Ca2+ channel isoforms for brain function. Biochem Soc Trans 34(Pt 5):903–909
Sun Q, Li QX, Song XF, Zheng SG, Yan F, Chen P, Tang JF, Niu YX, Bao QY, Zhang GQ, Hu YL (2012) Impact of CACNA1C polymorphisms on antihypertensive efficacy of calcium channel blocker. Zhonghua Xin Xue Guan Bing Za Zhi 40:3–7
Gasso P, Sanchez-Gistau V, Mas S, Sugranyes G, Rodriguez N, Boloc D, de la Serna E, Romero S, Moreno D, Moreno C, Diaz-Caneja CM, Lafuente A, Castro-Fornieles J (2016) Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disorders. Psychiatry Res 245:427–435
Bremer T, Man A, Kask K, Diamond C (2006) CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension. Pharmacogenomics 7:271–279
Yarlagadda A, Clayton AH (2009) Role of cholinergic system and calcium synchronization in schizophrenia. Psychiatry (Edgmont) 6:37–41
Tort AB, Dall'Igna OP, de Oliveira RV, Mantese CE, Fett P, Gomes MW, Schuh J, Souza DO, Lara DR (2005) Atypical antipsychotic profile of flunarizine in animal models. Psychopharmacology 177:344–348
Casamassima F, Hay AC, Benedetti A, Lattanzi L, Cassano GB, Perlis RH (2010) L-type calcium channels and psychiatric disorders: a brief review. Am J Med Genet B Neuropsychiatr Genet 153B(8):1373–1390
Chameau P, Qin Y, Spijker S, Smit AB, Joels M (2007) Glucocorticoids specifically enhance L-type calcium current amplitude and affect calcium channel subunit expression in the mouse hippocampus. J Neurophysiol 97(1):5–14
Dietsche B, Backes H, Laneri D, Weikert T, Witt SH, Rietschel M, Sommer J, Kircher T, Krug A (2014) The impact of a CACNA1C gene polymorphism on learning and hippocampal formation in healthy individuals: a diffusion tensor imaging study. Neuroimage 89:256–261
Bigos KL, Mattay VS, Callicott JH, Straub RE, Vakkalanka R, Kolachana B, Hyde TM, Lipska BK, Kleinman JE, Weinberger DR (2010) Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch Gen Psychiatry 67(9):939–945
Hasreiter J, Goldnagl L, Bohm S, Kubista H (2014) Cav1.2 and Cav1.3 L-type calcium channels operate in a similar voltage range but show different coupling to Ca(2+)-dependent conductances in hippocampal neurons. Am J Physiol Cell Physiol 306(12):C1200–C1213
Karst H, Nair S, Velzing E, Rumpff-van Essen L, Slagter E, Shinnick-Gallagher P, Joels M (2002) Glucocorticoids alter calcium conductances and calcium channel subunit expression in basolateral amygdala neurons. Eur J Neurosci 16(6):1083–1089
Acknowledgements
We would like to acknowledge the reviewers for their helpful comments on this paper.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The study was approved and supervised by the Ethics Committee of our hospital. Written informed consent was obtained from all study subjects and/or their legal guardians.
Funding
This study was supported by the National Key Research and Development Program of China (2016YFC0800701), the Science and Technology Committee of Shanghai Municipality (14DZ2270800/16DZ2290900/17DZ2273200); the Ministry of Finance, P.R. China (GY2014Z-2) and Shanghai Key Laboratory of Psychotic Disorders (13dz2260500).
Conflict of interest
The authors have declared that they have no competing interests.
Rights and permissions
About this article
Cite this article
Zhang, SY., Hu, Q., Tang, T. et al. Role of CACNA1C gene polymorphisms and protein expressions in the pathogenesis of schizophrenia: a case-control study in a Chinese population. Neurol Sci 38, 1393–1403 (2017). https://doi.org/10.1007/s10072-017-2963-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-017-2963-0